Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M90.6Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M-7.6EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %5.1PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M6,800,476ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with MZF

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

MZF is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


MZF: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rapps, MichaelDirector, Director or Senior Officer of 10% Securi 2017-01-16Buy1,200$9.4840.61view
Gridley, Anthony RonaldSenior Officer 2017-01-16Sell1,800$16.94-21.31view
DINWOODIE, TYLER WAYNE PAULSenior Officer 2017-01-16Buy4,000$0.177741.18view
Brown, Mark ThomasDirector 2017-01-16Sell29,300$1.36880.15view
Bebek, IvanDirector 2017-01-16Buy8,990$3.38294.38view
smith, laurie james10% Security Holder, Director, Senior Officer 2017-01-16Buy7,500$0.413151.22view
MEHR, JEFFREYSenior Officer 2017-01-13Sell50,000$27.91-52.24view
Squibb, Geoffrey WayneDirector 2017-01-13Buy267$6.27112.6view
Smith, DavidSenior Officer 2017-01-13Sell15,000$60.38-77.92view
Rowlands, William BruceDirector, Senior Officer 2017-01-13Buy20,000$0.158786.67view

Quarterly/Annual Reports about MZF:

    News about MZF:

    Articles On GuruFocus.com
    Cisco: A 10% Dividend Increase Could Be On the Way Jan 22 2017 
    If You Think Intel Is Dead Money, Think Again Jan 22 2017 
    AbbVie Gets FDA Approval for Lymphoma Drug Jan 22 2017 
    Activision Blizzard Is Poised to Move Higher Jan 22 2017 
    3 Great Stocks for Your 2017 Core Investment Portfolio Jan 22 2017 
    BioCorRx Receives New Funding for Opioid Drug Jan 22 2017 
    3M Could Increase Dividend by Up to 10% Jan 22 2017 
    2018 Will Be IBM CEO Ginni Rometty’s Year of Vindication Jan 22 2017 
    Why Barrick Gold Is a Long Term Pick Jan 21 2017 
    Will Samsung Be Able to Repair Its Brand Image? Jan 21 2017 

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)